Draig Therapeutics: Funding, Investors & Team (Sep 2026)
Draig Therapeutics is a clinical-stage biopharmaceutical company that develops investigational therapies for neuropsychiatric disorders.
Draig Therapeutics has raised $65.0M across 1 funding round on record, the most recent a Series B of $65.0M announced in Jul 2026.
That round is above the $4.0M median round size for United Kingdom companies tracked on FundedIQ over the last two years.
Draig Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Draig Therapeutics Funding Rounds
Draig Therapeutics Investors
12 investors are recorded in total; the 5 named above are those the record identifies.
Draig Therapeutics Founders and Leadership Team
Contact details for the Draig Therapeutics team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Draig Therapeutics Funding in Context
Draig Therapeutics' latest round of $65.0M is above the median round in United Kingdom. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Draig Therapeutics in Biopharma and Cardiff
Companies Similar to Draig Therapeutics
Ryft is a payment platform that aims to facilitate the growth of marketplaces and digital platforms in the…
Transformational protein technology for fat replacement, texture enhancement and nutrient delivery in the…
Quartz provides a personal wealth platform that aggregates financial accounts and offers personalized…
Chestnut Bio Polymers develops plant-based biopolymer formulations to replace conventional fossil-based…
iGii develops innovative manufacturing process that enables the company to produce high performing, pure, 3D…
Axo Longevity offers membership-based biomarker testing and digital health plans for preventive wellness and…
OriginalVoices is providing real human context for AI agents and workflows using a network of over 40,000…
Fuse Diagnostics vision is to give lab quality diagnostic information wherever it is required through…
AcademyAI is an enterprise workforce development platform that assesses and builds AI skills across an…
Eichler offers an AI-native platform that helps real estate agents with mortgage origination and brokerage…
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
Resolutiion provides AI software for commercial conflict management and delivery risk monitoring.
Draig Therapeutics Funding FAQs
What does Draig Therapeutics do?
Draig Therapeutics is a clinical-stage biopharmaceutical company that develops investigational therapies for neuropsychiatric disorders.
How much funding has Draig Therapeutics raised?
Draig Therapeutics has raised $65.0M across 1 round on record. The most recent is a Series B of $65.0M announced in Jul 2026.
When did Draig Therapeutics last raise funding?
Draig Therapeutics' most recent funding round on record is a Series B of $65.0M, announced in Jul 2026.
Who has invested in Draig Therapeutics?
Investors on record for Draig Therapeutics include British Business Bank, Janus Henderson Investors, Schroders Capital, Canaan Partners, Intermediate Capital Group. FundedIQ records 12 investors in total.
Who founded Draig Therapeutics?
FundedIQ lists Simon Ward (Founder & Chief Scientific & Development Officer (CSDO)) at Draig Therapeutics.
Who is the CEO of Draig Therapeutics?
Ivana Magovcevic-Liebisch is listed as President and CEO at Draig Therapeutics.
Where is Draig Therapeutics headquartered?
Draig Therapeutics is based in Cardiff, United Kingdom.
How many employees does Draig Therapeutics have?
Draig Therapeutics is in the 11-50 employee band.
When was Draig Therapeutics founded?
Draig Therapeutics was founded in 2024.
About FundedIQ's Draig Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Draig Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.